Genmab News

Mar 30, 2020 at 5:41 PM EDT Genmab Files Annual Report with the U.S. Securities and Exchange Commission	Download
Mar 26, 2020 at 4:13 PM EDT Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons	Download
Mar 26, 2020 at 3:54 PM EDT Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and a New Member of Management, and Grant of Restricted Stock Units and Warrants to Employees and a New Member	Download
Mar 26, 2020 at 10:26 AM EDT Passing of Genmab A/S’ Annual General Meeting	Download
Mar 12, 2020 at 11:33 AM EDT Genmab A/S Provides Update to Annual General Meeting	Download
Mar 10, 2020 at 1:09 AM EDT Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer	Download
Feb 27, 2020 at 4:03 AM EST Notice to Convene the Annual General Meeting of Genmab A/S	Download
Feb 26, 2020 at 12:30 PM EST Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons	Download
Feb 26, 2020 at 11:09 AM EST Genmab A/S has published its Articles of Association	Download
Feb 25, 2020 at 3:41 PM EST Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons	Download
Feb 25, 2020 at 3:28 PM EST Capital Increase in Genmab as a Result of Employee Warrant Exercise	Download
Feb 24, 2020 at 1:32 AM EST U.S. FDA Filing Acceptance and Priority Review for sBLA, Submitted by Novartis, for Ofatumumab in Relapsing Multiple Sclerosis	Download
Feb 21, 2020 at 3:20 PM EST Genmab Board of Directors Chairman to Step Down	Download
Feb 19, 2020 at 11:05 AM EST Genmab Publishes 2019 Annual Report	Download
Jan 23, 2020 at 4:38 AM EST Horizon Therapeutics Secures U.S. FDA Approval for Teprotumumab, for the Treatment of Thyroid Eye Disease (TED)	Download
Jan 22, 2020 at 6:32 AM EST Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen	Download
Jan 20, 2020 at 12:02 PM EST Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma	Download
Jan 06, 2020 at 9:54 AM EST Genmab to Present at the 38th Annual J.P. Morgan Healthcare Conference	Download
Jan 02, 2020 at 4:26 PM EST Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons	Download
Jan 02, 2020 at 9:29 AM EST Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons	Download

NEWS & EVENTS

Through timely company announcements, media releases, events and presentations, Genmab discloses and informs all our stakeholders of key events throughout the year.

Genmab News

Genmab News

Who we are

Turning insights into medicine

Innovation for the future

Genmab A/S

Genmab B.V.

Genmab US, Inc.

Genmab K.K.

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.